Recombinant Human ADH1C protein (His tag C-Terminus)
Be the first to review this product! 리뷰 제출
|
(0 출판물)
Recombinant Human ADH1C protein (His tag C-Terminus) is a Human Full Length protein, in the 1 to 375 aa range, expressed in Baculovirus infected insect cells, with >95%, < 1 EU/µg endotoxin level, suitable for SDS-PAGE.
대체 명칭 보기
ADH3, ADH1C, Alcohol dehydrogenase 1C, Alcohol dehydrogenase subunit gamma
- SDS-PAGE
Supplier Data
SDS-PAGE - Recombinant Human ADH1C protein (His tag C-Terminus) (AB219448)
15% SDS-PAGE analysis of ab219448 (3μg).
Reactivity 정보
서열 정보
특성 및 보관 정보
제형
Purification 테크닉
배송 시 보관 조건
적절한 단기 보관 기간
적절한 단기 보관 조건
적절한 장기 보관 조건
분주 정보
보관 정보
추가 정보
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Alcohol dehydrogenase 1C significantly influences the metabolism of alcohols in the liver. It contributes to the alcohol dehydrogenase complex which includes similar enzymes such as ADH1A and ADH1B. These enzymes work collaboratively to convert ethanol into acetaldehyde the first step in alcohol metabolism. ADH1C's activity affects the rate at which alcohol is processed impacting the accumulation of acetaldehyde which can be toxic in high concentrations.
Pathways
Alcohol dehydrogenase 1C plays a significant part in the ethanol metabolism pathway and the retinol metabolism pathway. In these pathways ADH1C interacts with other enzymes that facilitate the conversion of alcohols and retinoids into corresponding metabolites. ADH1C relates closely with aldehyde dehydrogenase proteins like ALDH2 which further processes acetaldehyde into acetate a less harmful substance. These pathways illustrate how ADH1C integrates into broader metabolic processes.
일반 정보
기능
Alcohol dehydrogenase. Exhibits high activity for ethanol oxidation and plays a major role in ethanol catabolism.
서열 유사성
Belongs to the zinc-containing alcohol dehydrogenase family.
타겟 정보
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com